SCHEMBL12467265

SCHEMBL12467265

Cc1cc(O)n(-c2ccc(C(=O)O)cc2)n1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.63
GFER P55789 1/20 0.63
ALDH1A1 P00352 5/20 0.54
HPGD P15428 4/20 0.54
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
POLB P06746 2/20 0.53
HTT P42858 1/20 0.52
MAPT P10636 4/20 0.50
NPC1 O15118 1/20 0.50
TP53 P04637 1/20 0.50
RAB9A P51151 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
KDM6B O15054 1/20 0.50
ABCC4 O15439 1/20 0.50
KDM4A O75164 1/20 0.50
ABCB11 O95342 1/20 0.50
KDM5A P29375 1/20 0.50
BLVRB P30043 1/20 0.50
SCN5A Q14524 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL600209 0.85 GAA (0.65) GAAGFERALDH1A1HPGDMEN1
SCHEMBL31420309 0.84 GAA (0.55) GAAGFERALDH1A1HPGDMEN1
SCHEMBL3011187 0.84 GAA (0.55) GAAGFERALDH1A1HPGDMEN1
SCHEMBL25298082 0.83 KDM4A (0.55) GAAGFERALDH1A1HPGDKMT2A
SCHEMBL200831 0.82 MAPK1 (0.63) GAAALDH1A1HPGDKMT2AMAPT
SCHEMBL11687973 0.82 CYP1A2 (0.65) GAAGFERALDH1A1HPGDMEN1
SCHEMBL7136438 0.81 ALDH1A1 (0.80) GAAGFERALDH1A1HPGDMEN1
SCHEMBL31420390 0.81 GAA (0.54) GAAGFERALDH1A1HPGDMEN1
SCHEMBL11441588 0.80 CYP1A2 (0.47) GAAALDH1A1HPGDMEN1KMT2A
SCHEMBL28620570 0.80 MAPK1 (0.47) GAAGFERALDH1A1HPGDPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059469-A1 SUBSTITUTED AMINOPYRIDINE COMPOUNDS AS AKT INHIBITORS ATAVISTIK BIO, INC. (US) 2025-03-20 WO disclosed
US-7985266-B2 Keratin dyeing compositions comprising a radical scavenger and a chelant and use thereof THE PROCTER & GAMBLE COMPANY (US) 2011-07-26 US disclosed
US-20110035886-A1 Keratin Dyeing Compositions Comprising a Radical Scavenger and a Chelant and Use Thereof NOXELL CORPORATION 2011-02-17 US disclosed
WO-2010123866-A2 KERATIN DYEING COMPOSITIONS COMPRISING A RADICAL SCAVENGER AND A CHELANT AND USE THEREOF THE PROCTER & GAMBLE COMPANY (US) 2010-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110035886-A1 Keratin Dyeing Compositions Comprising a Radical Scavenger and a Chelant and Use Thereof KRT18, LPO, KRTCAP2 GAA 1970/4885GFER 47/4885ALDH1A1 354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.